Cargando…
Aetiology and presentation of childhood pleural infections in the post-pneumococcal conjugate vaccine era in South Africa
BACKGROUND: Complications of respiratory infections including pleural effusion (PE) are associated with a high morbidity. Differentiating between PE caused by Mycobacterium tuberculosis (Mtb) infection and other bacterial infections in endemic areas is difficult in children, thus, impacting treatmen...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
South African Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948474/ https://www.ncbi.nlm.nih.gov/pubmed/35359691 http://dx.doi.org/10.7196/AJTCCM.2021.v27i4.152 |
_version_ | 1784674667034836992 |
---|---|
author | Golden, L Chaya, S Reichmuth, K Visagie, A Ayuk, A Kwarteng Owusu, S Marangu, D Affendi, N Lakhan, A Gray, D Vanker, A Zar, H Zampoli, M |
author_facet | Golden, L Chaya, S Reichmuth, K Visagie, A Ayuk, A Kwarteng Owusu, S Marangu, D Affendi, N Lakhan, A Gray, D Vanker, A Zar, H Zampoli, M |
author_sort | Golden, L |
collection | PubMed |
description | BACKGROUND: Complications of respiratory infections including pleural effusion (PE) are associated with a high morbidity. Differentiating between PE caused by Mycobacterium tuberculosis (Mtb) infection and other bacterial infections in endemic areas is difficult in children, thus, impacting treatment. OBJECTIVES: To investigate the aetiology of PE and features distinguishing tuberculosis (TB) from bacterial PE in children. METHODS: We conducted a prospective study in children with PE admitted to a tertiary hospital in Cape Town from December 2017 to December 2019. Clinical information and routine laboratory investigations were compared between children with bacterial, Mtb or unclassified PE, categorised according to study definitions. RESULTS: A total of 91 patients were included in the present study and their median age was 31 months (interquartile range (IQR) 11.8 - 102.1). The aetiology was bacterial in 40% (n=37), Mtb in 39% (n=36) and unclassified in 20% (n=18) of patients. Staphylococcus aureus was the most common bacterial isolate, confirmed in 65% (n=24/37) patients, and Streptococcus pneumoniae was confirmed in only 8% of patients. TB was microbiologically confirmed in 33% (n=12/36) of patients. Patients with TB were older (91.6 v. 11.8 months; p<0.001), with more weight loss (28 v. 12 patients; p<0.001), and longer cough duration (10 v. 4 days; p<0.001) than those with other bacterial PE. In contrast, the latter had significantly higher serum C-reactive protein (median 250 v. 122 mg/L; p<0.001), procalcitonin (11 v. 0.5 mg/L; p<0.001), pleural fluid lactate dehydrogenase (7 280 v. 544 U/L; p<0.001), and adenosine deaminase levels (162 v. 48 U/L; p<0.001) and lower glucose levels (1.3 v. 4 mmol/L; p<0.001). CONCLUSION: Post 13-valent pneumococcal conjugate vaccine, S. aureus is the dominant cause of PE in children using traditional culture methods, while Mtb remains a common cause of PE in our setting. Useful clinical and laboratory differences between Mtb and other bacterial PE were identified, but the cause of PE in 20% of children was underdetermined. Molecular testing of pleural fluid for respiratory pathogens may be useful in such children. |
format | Online Article Text |
id | pubmed-8948474 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | South African Medical Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-89484742022-03-30 Aetiology and presentation of childhood pleural infections in the post-pneumococcal conjugate vaccine era in South Africa Golden, L Chaya, S Reichmuth, K Visagie, A Ayuk, A Kwarteng Owusu, S Marangu, D Affendi, N Lakhan, A Gray, D Vanker, A Zar, H Zampoli, M Afr J Thorac Crit Care Med Research BACKGROUND: Complications of respiratory infections including pleural effusion (PE) are associated with a high morbidity. Differentiating between PE caused by Mycobacterium tuberculosis (Mtb) infection and other bacterial infections in endemic areas is difficult in children, thus, impacting treatment. OBJECTIVES: To investigate the aetiology of PE and features distinguishing tuberculosis (TB) from bacterial PE in children. METHODS: We conducted a prospective study in children with PE admitted to a tertiary hospital in Cape Town from December 2017 to December 2019. Clinical information and routine laboratory investigations were compared between children with bacterial, Mtb or unclassified PE, categorised according to study definitions. RESULTS: A total of 91 patients were included in the present study and their median age was 31 months (interquartile range (IQR) 11.8 - 102.1). The aetiology was bacterial in 40% (n=37), Mtb in 39% (n=36) and unclassified in 20% (n=18) of patients. Staphylococcus aureus was the most common bacterial isolate, confirmed in 65% (n=24/37) patients, and Streptococcus pneumoniae was confirmed in only 8% of patients. TB was microbiologically confirmed in 33% (n=12/36) of patients. Patients with TB were older (91.6 v. 11.8 months; p<0.001), with more weight loss (28 v. 12 patients; p<0.001), and longer cough duration (10 v. 4 days; p<0.001) than those with other bacterial PE. In contrast, the latter had significantly higher serum C-reactive protein (median 250 v. 122 mg/L; p<0.001), procalcitonin (11 v. 0.5 mg/L; p<0.001), pleural fluid lactate dehydrogenase (7 280 v. 544 U/L; p<0.001), and adenosine deaminase levels (162 v. 48 U/L; p<0.001) and lower glucose levels (1.3 v. 4 mmol/L; p<0.001). CONCLUSION: Post 13-valent pneumococcal conjugate vaccine, S. aureus is the dominant cause of PE in children using traditional culture methods, while Mtb remains a common cause of PE in our setting. Useful clinical and laboratory differences between Mtb and other bacterial PE were identified, but the cause of PE in 20% of children was underdetermined. Molecular testing of pleural fluid for respiratory pathogens may be useful in such children. South African Medical Association 2021-12-31 /pmc/articles/PMC8948474/ /pubmed/35359691 http://dx.doi.org/10.7196/AJTCCM.2021.v27i4.152 Text en https://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution - NonCommercial Works License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Golden, L Chaya, S Reichmuth, K Visagie, A Ayuk, A Kwarteng Owusu, S Marangu, D Affendi, N Lakhan, A Gray, D Vanker, A Zar, H Zampoli, M Aetiology and presentation of childhood pleural infections in the post-pneumococcal conjugate vaccine era in South Africa |
title | Aetiology and presentation of childhood pleural infections in the post-pneumococcal conjugate vaccine era in South Africa |
title_full | Aetiology and presentation of childhood pleural infections in the post-pneumococcal conjugate vaccine era in South Africa |
title_fullStr | Aetiology and presentation of childhood pleural infections in the post-pneumococcal conjugate vaccine era in South Africa |
title_full_unstemmed | Aetiology and presentation of childhood pleural infections in the post-pneumococcal conjugate vaccine era in South Africa |
title_short | Aetiology and presentation of childhood pleural infections in the post-pneumococcal conjugate vaccine era in South Africa |
title_sort | aetiology and presentation of childhood pleural infections in the post-pneumococcal conjugate vaccine era in south africa |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948474/ https://www.ncbi.nlm.nih.gov/pubmed/35359691 http://dx.doi.org/10.7196/AJTCCM.2021.v27i4.152 |
work_keys_str_mv | AT goldenl aetiologyandpresentationofchildhoodpleuralinfectionsinthepostpneumococcalconjugatevaccineerainsouthafrica AT chayas aetiologyandpresentationofchildhoodpleuralinfectionsinthepostpneumococcalconjugatevaccineerainsouthafrica AT reichmuthk aetiologyandpresentationofchildhoodpleuralinfectionsinthepostpneumococcalconjugatevaccineerainsouthafrica AT visagiea aetiologyandpresentationofchildhoodpleuralinfectionsinthepostpneumococcalconjugatevaccineerainsouthafrica AT ayuka aetiologyandpresentationofchildhoodpleuralinfectionsinthepostpneumococcalconjugatevaccineerainsouthafrica AT kwartengowusus aetiologyandpresentationofchildhoodpleuralinfectionsinthepostpneumococcalconjugatevaccineerainsouthafrica AT marangud aetiologyandpresentationofchildhoodpleuralinfectionsinthepostpneumococcalconjugatevaccineerainsouthafrica AT affendin aetiologyandpresentationofchildhoodpleuralinfectionsinthepostpneumococcalconjugatevaccineerainsouthafrica AT lakhana aetiologyandpresentationofchildhoodpleuralinfectionsinthepostpneumococcalconjugatevaccineerainsouthafrica AT grayd aetiologyandpresentationofchildhoodpleuralinfectionsinthepostpneumococcalconjugatevaccineerainsouthafrica AT vankera aetiologyandpresentationofchildhoodpleuralinfectionsinthepostpneumococcalconjugatevaccineerainsouthafrica AT zarh aetiologyandpresentationofchildhoodpleuralinfectionsinthepostpneumococcalconjugatevaccineerainsouthafrica AT zampolim aetiologyandpresentationofchildhoodpleuralinfectionsinthepostpneumococcalconjugatevaccineerainsouthafrica |